A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
- 25 February 2010
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 28 (9), 2076-2079
- https://doi.org/10.1016/j.vaccine.2009.12.041
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Protective Immunity Afforded by Inactivated H5N1 (NIBRG‐14) Vaccine Requires Antibodies against Both Hemagglutinin and Neuraminidase in MiceThe Journal of Infectious Diseases, 2009
- Seasonal inactivated influenza virus vaccinesVaccine, 2008
- Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsVaccine, 2007
- Treatment of Influenza Virus-Infected SCID Mice with Nonneutralizing Antibodies Specific for the Transmembrane Proteins Matrix 2 and Neuraminidase Reduces the Pulmonary Virus Titer but Fails to Clear the InfectionVirology, 1999
- Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humansVaccine, 1995
- Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substratesJournal of Immunological Methods, 1990
- Clinical and Immunologic Evaluation of NeuraminidaseSpecific Influenza A Virus Vaccine in HumansThe Journal of Infectious Diseases, 1977
- Characterization of temperature sensitive influenza virus mutants defective in neuraminidaseVirology, 1974
- Induction of Partial Immunity to Influenza by a Neuraminidase-specific VaccineThe Journal of Infectious Diseases, 1974
- Association of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in ManNew England Journal of Medicine, 1972